↓ Skip to main content

Cost-effectiveness analysis of fruquintinib for metastatic colorectal cancer third-line treatment in China

Overview of attention for article published in BMC Cancer, October 2020
Altmetric Badge

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness analysis of fruquintinib for metastatic colorectal cancer third-line treatment in China
Published in
BMC Cancer, October 2020
DOI 10.1186/s12885-020-07486-w
Pubmed ID
Authors

Zhi Peng, Xingduo Hou, Yangmu Huang, Tong Xie, Xinyang Hua

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 24%
Researcher 4 16%
Student > Ph. D. Student 2 8%
Lecturer 1 4%
Student > Doctoral Student 1 4%
Other 2 8%
Unknown 9 36%
Readers by discipline Count As %
Medicine and Dentistry 4 16%
Nursing and Health Professions 3 12%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Psychology 2 8%
Business, Management and Accounting 1 4%
Other 4 16%
Unknown 9 36%